Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0 Master Protocol Using the CIVO® Platform to Evaluate Intratumoral Microdoses of Anti-Cancer Therapies in Patients With Solid Tumors

NCT04541108 is registered in ClinicalTrials.gov with Presage Biosciences as lead sponsor.

NCT NCT04541108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04541108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0 Master Protocol Using the CIVO® Platform to Evaluate Intratumoral Microdoses of Anti-Cancer Therapies in Patients With Solid Tumors
Lead sponsor
Presage Biosciences
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 26, 2021
Completion date
December 31, 2031
Enrollment
15 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor